The U.S., which is also in the process of reviewing the drug, has reached a deal to buy 1.7 million courses of molnupiravir at a cost of approximately $866 each.
blueskygg(Grass)
The U.S. pharmaceutical giant Merck & Co. says it is in early discussions with the federal government to sell it stocks of the company's experimental COVID-19 drug.
The U.S., which is also in the process of reviewing the drug, has reached a deal to buy 1.7 million courses of molnupiravir at a cost of approximately $866 each.
-blueskygg(Grass);
2021-11-5{664}(#14089230@0)
The U.S. pharmaceutical giant Merck & Co. says it is in early discussions with the federal government to sell it stocks of the company's experimental COVID-19 drug.
